By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
July 20, 2022

A New COVID-19 Vaccine Option

Stephen Massey

While all the COVID-19 vaccines have been proven safe and effective, employees who still have concerns about the cutting-edge science of the mRNA vaccines from Pfizer-BioNTech and Moderna now have a new option based on old technology: the Novavax vaccine.

Novavax’s COVID-19 vaccine was authorized for adults earlier this week. 

It works on the same, well-established process that vaccines have used for 30 years. It uses harmless proteins of the COVID-19 virus to trigger a response from your immune system when it recognizes those proteins again if you’re infected by the virus. That method of priming your immune system also results in fewer side effects after vaccination. 

The Novavax vaccine will be available in the coming weeks, and it will be free.

We’ve updated our Conversation Guide for Managers and COVID-19 Vaccines Overview to help you promote this new vaccine option.